NASDAQ · ALHC

Alignment Healthcare, Inc.

$18.59 -$0.84 (-4.35%) 1D Market open
Session Pulse Regular session 1 mentions on Wed · 0 bullish / 1 bearish tags No new SEC filings since Mon close its sector ranked 4/11 this week Full pulse →

Key Metrics

$4.02B
Market cap
202.81×
P/E · TTM
$4.26B
Revenue · TTM
$19.81M
Net income
EPS · TTM $0.10
Dividend yield
Free cash flow $226.10M
Beta · 1Y 0.55
EBITDA · TTM $50.47M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jul 8
    The stock moved -16.7% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jul 8
  • Jun 9
    The stock moved +25.1% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 9
  • Jun 1
    From its Feb 3 high, the share price fell 42%.

    Peak close $22.89 on Feb 3; trough close $13.30 on Jun 1. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -42%

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$4.02B
Enterprise value$3.61B
Shares outstanding206.7M
52-wk range$11.73 – $25.12
Avg volume · 20D1.6M
Net cash $402.68M
Book value / share$1.07
IndustryHospital & Medical Service Plans
ExchangeNASDAQ
About Alignment Healthcare, Inc.
IPO dateMar 26, 2021
Employees1849

Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E202.81
P/S0.94
P/FCF17.77
EV/EBITDA71.62
EV/Sales0.85
Graham №$1.57

Profitability

Gross
Operating 0.5%
Net 0.5%
FCF 5.3%
ROE / ROIC 12.9% · -10.1%

Financial Health

Current ratio1.58
Quick ratio
Debt / equity1.56
Debt / EBITDA 6.41
Net cash $402.68M
Working capital$420.61M

Cash Flow · TTM

Operating CF $251.99M
Capex −$25.89M
Free cash flow $226.10M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

5 / 9
Middling fundamentals · 5 of 9 signals passing

Altman Z-Score

5.0
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$1.57 vs $18.67
Trades 11.9× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings